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Abstract
Introduction: Amyotrophic lateral sclerosis is a rapidly progressive, fatal neurodegenerative disorder for which
there is no effective treatment. The diagnosis is dependent on the clinical presentation and consistent
electrodiagnostic studies. Typically, there is a combination of upper and lower motor neuron signs as well as
electrodiagnostic studies indicative of diffuse motor axonal injury. The presentation of amyotrophic lateral sclerosis,
however, may be variable. At the same time, the diagnosis is essential for patient prognosis and management. It is
therefore important to appreciate the range of possible presentations of amyotrophic lateral sclerosis.
Case presentation: We present the case of a 57-year-old Caucasian man with pathological findings on
postmortem examination consistent with amyotrophic lateral sclerosis but atypical clinical and electrodiagnostic
features. He died after a rapid course of progressive weakness. The patient did not respond to immunosuppressive
therapy.
Conclusion: Amyotrophic lateral sclerosis should be considered in patients with a rapidly progressive, unexplained
neuropathic process. This should be true even if there are atypical clinical and electrodiagnostic findings. Absence
of response to therapy and the development of upper motor neuron signs should reinforce the possibility that
amyotrophic lateral sclerosis may be present. Since amyotrophic lateral sclerosis is a fatal illness, however, the
possibility of this disease in patients with atypical clinical features should not diminish the need for a thorough
diagnostic evaluation and treatment trials.
Introduction
Amyotrophic lateral sclerosis (ALS) is a progressive neu-
rodegenerative disorder characterized by anterior horn
cell and corticospinal degeneration, primarily involving
motor neurons in the cerebral cortex, brainstem, and
spinal cord. Despite its recognition for over 140 years,
ALS remains a poorly understood, usually rapidly pro-
gressive and fatal disease. More than 60% of patients
with ALS die within three years [1]. Riluzole is the only
recognized medication treatment and its effect is mod-
est, prolonging life for only two to three months [2].
Given this, an accurate diagnosis is critical. A primary
responsibility for the physician caring for patients with
ALS is considering other potentially treatable illnesses
including an acquired neuropathy.
Although criteria are available for diagnosing ALS
[3,4], the diagnosis may be difficult given the variability
of clinical findings and absence of a biological marker.
The importance of electrodiagnostic studies in making a
diagnosis of ALS has recently been emphasized [3]. We
describe he case of a patient who had clinical and elec-
trodiagnostic features that would be unusual for ALS,
and yet was found to have pathological findings indica-
tive of ALS on post-mortem examination. This study
emphasizes the limitations of using currently accepted
clinical and electrodiagnostic criteria in diagnosing ALS.
Case presentation
A 57-year-old Caucasian man with no known past medi-
cal history presented two months after the onset of
bilateral lower extremity weakness. The weakness initi-
ally affected his right leg, with subsequent progression
to his left leg. He then noted ‘muscle twitching’.T h e r e
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months prior to his illness he had been painting his
house and reportedly was exposed to mold. Examination
showed mild decrease in strength at the hips and knees
with a somewhat more pronounced decrease at the
ankles and toes, more prominent on the right side than
the left. Strength in the arms was preserved. Fascicula-
tions were observed in the arms and legs. Initial sensory
exam revealed decreased position in the toes and
decreased vibration in the legs. Cerebellar examination
was unremarkable. Reflexes were present and symmetri-
cal except for absent Achilles’ reflexes. He was unable to
stand from sitting without using his arms for support,
nor able to walk unassisted. Electrodiagnostic studies
(initial; see below) revealed findings consistent with a
polyneuropathy, possibly multifocal. Laboratory testing
(see below) did not reveal a cause for the patient’sd i f f i -
culties. An elevated protein in the cerebrospinal fluid
was thought consistent with an acquired neuropathy. He
was given a presumptive diagnosis of a chronic acquired
demyelinating polyneuropathy (CIDP) and received a
course of intravenous immunoglobulin (0.4 g/kg over
four days) without symptomatic relief. He was then
started on prednisone (60 mg daily) and azathioprine
(150 mg daily). Computed tomography (CT) scans of
the chest and abdomen were unremarkable as was a gal-
lium scan. MRI scans of the entire spine were unreveal-
ing except for some mild degenerative changes in the
lumbar region. His weakness worsened with progressive
decreased movement in the legs as well as weakness in
the arms associated with atrophy in intrinsic hand mus-
cles. He was admitted for further workup. A left sural
nerve biopsy revealed findings of a chronic axonal
neuropathy with active Wallerian degeneration and
remyelination without evidence of inflammation. The
patient was treated with plasmapheresis (equivalent of
o n ep l a s m av o l u m ef i v et i m e si n1 4d a y s )a n dd i s -
charged to a nursing home on prednisone and
azathioprine. He was non-ambulatory. Five months later
he returned to the clinic with worsening of his lower
extremity weakness. Otherwise, his examination was the
same except that reflexes were now brisk without spread
and persistently absent Achilles’ reflexes. Babinski signs
were not present. A second electrodiagnostic examina-
tion five months after the initial study (repeat; see
below) showed findings consistent with a progressive
polyneuropathy. He continued to symptomatically dete-
riorate, and was admitted for intravenous cyclophospha-
mide. He died one month later of cardiorespiratory
failure at age 58, seven months after symptom onset.
There is no known family history of similar problems in
a large well, known family. Electrodiagnostic studies
(Table 1) were performed according to standard proto-
cols used in the Clinical Neurophysiology Laboratories
at the Hines Veterans Administration Hospital. F-waves
were analyzed following 20 supramaximal stimuli. On
needle electromyography (EMG) in the initial study,
fibrillations and positive sharp waves were limited to the
leg muscles with associated voluntary motor unit activa-
tion present distally. Fasciculations were present in the
proximal arms and legs. The right tibial motor conduc-
tion velocity was in a demyelinating range and that for
the right peroneal nerve was borderline [5]. There was a
meaningful difference in conduction velocities between
the right and left legs [6]. Distal motor latencies were
diffusely prolonged in the feet, sensory conductions
Table 1 Electrodiagnostic Studies
Initial Repeat
Right Left Right
Study Nerve DML (ms) AMP (mV) CV (m/sec) DML (ms) AMP (mV) CV (m/sec) DML (ms) AMP (mV) CV (m/sec)
Motor Tibial (AH) 6.6 0.4 26 7.4 1 37 NR NR NR
Peroneal (EDB) 7.9 0.1 29 7.9 12 37 NR NR NR
Median (APB) 4.4 7 51 6.4 0.7 29.6
Ulnar (ADM) 3.4 8 56 3.5 2.4 47
Sensory Sural 21.2 31
Median(dig 2) 13 53 3.6 44
Median(dig 3) 9.4 49
Ulnar 8.7 46 3.0 42
Mean F-wave latency (ms) Mean F-wave latency (ms)
F-Wave Tibial(soleus) NR
Median (APB) 33 (predicted 28.9) 41.4 (predicted 28.9)
Normal values: DML - peroneal ≤ 6.1 ms; tibial ≤ 6.4 ms; median ≤ 4.5 ms; ulnar ≤ 3.4 ms. MNCV (amplitudes) - tibial ≥ 39 m/sec (≥ 4 mV); peroneal ≥ 39 m/sec
(≥ 3 mV); median ≥ 49 m/sec (≥ 4 mV); ulnar ≥ 49 m/sec (≥ 4 mV). SNAP conduction velocities (amplitudes) - sural ≥ 39 m/sec (≥ 6 μ); median ≥ 49 m/sec (10
μV); ulnar ≥ 49 m/sec (≥ 3 μV). Abnormal values in bold.
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in the arms were slowed despite unremarkable median
motor conduction studies. A repeat examination three
months later revealed findings that would be consistent
with progression of a peripheral neuropathic process.
Fibrillations and positive sharp waves were now present
in the hands with associated decreased motor unit acti-
vation. Voluntary motor unit activation in the legs was
absent distally and decreased proximally. Evoked motor
responses were absent stimulating in the legs including
recording from the tibialis anterior. The right median
conduction velocity was in a demyelinating range with
prominent prolongation of the median distal motor
latency and median F-wave latency. There was meaning-
ful asymmetry between the tested right median motor
conduction velocity (29 m/sec) and that for the ulnar
nerve (47 m/sec) [6]. There was no evidence for conduc-
tion block or temporal dispersion. Measurements for the
motor conduction studies included negative peak and
total durations as well as negative peak areas (Table 1).
Recording sites in parentheses, median and ulnar Sen-
sory conduction studies were performed orthodromi-
cally. Predicted F-wave latencies were based on
regression equations including age and limb length [7].
Extensive laboratory evaluations in this patient did
not reveal a cause for his neuropathies. A complete
blood count and a basic metabolic profile were all
within normal limits as were studies of thyroid func-
tion and B12. A serum protein electrophoresis, pros-
tate specific antigen, and urine for heavy metals were
all unrevealing. This was also true for antibodies for
Lyme disease and human immunodeficiency virus as
well cultures for campylobacter jejuni. A complete
SensoriMotor Neuropathy Profile and a NeoComplete
Paraneoplastic Profile [Athena
R, Worcester, MA] were
unremarkable. These studies included assays for anti-
GM1, anti-GD1, and myelin associated glycoprotein
( M A G )a n t i b o d i e sa sw e l la ss t u d i e sf o rH u ,M a ,a n d
Yo antigens. Cerebrospinal protein was elevated (73
mg/dl; normal ≤ 45). There were no cells or oligoclo-
nal bands.
A post-mortem examination was obtained. There was
loss of anterior horn cells, some with ubiquitin positive
inclusions, and associated astrocytosis of the anterior
horns throughout the entire length of the spinal cord.
Lewy body-like (Figure 1) and skein-like inclusions were
present. The lateral and anterior columns showed exten-
sive vacuolar degeneration with macrophages and reac-
tive gliosis. The posterior columns were preserved. The
corticospinal tracts of the m e d u l l aw e r em i l d l yv a c u o -
lated. The motor nuclei of the brainstem and cortex
showed mild degenerative changes. There was no evi-
dence of inflammation anywhere throughout the
neuraxis.
Sections of peripheral nerve revealed loss of nerve
fiber with extensive axonal degeneration and active Wal-
lerian degeneration. There were a few CD26 positive B
lymphocytes thought to be a nonspecific finding or a
reaction of extensive degeneration. The muscle showed
extensive atrophy with fiber type grouping and angu-
lated fibers. There was no muscle inflammation. The
final diagnoses from the autopsy were spinal cord show-
ing extensive degeneration of anterior horn cells and
tracts consistent with ALS and axonal degeneration of
peripheral nerve.
Discussion
When first seen, the patient had none of the requisite
combination of upper and lower motor neuron signs
consistent with ALS [3,4]. Although he subsequently
developed brisk reflexes, at no time was there spread of
the reflexes nor pathological reflexes such as Babinski
responses. The asymmetry of leg weakness would be
consistent with ALS. Asymmetric weakness, however, is
also consistent with an acquired neuropathic process
with demyelinating features [8,9]. Fasciculations were
present and are a characteristic clinical finding in ALS.
Fasciculations, however, are a non-specific finding
Figure 1 Ubiquitin stain of the anterior horn neurons with
Lewy body-like inclusions. High powered field.
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not considered of clinical significance for ALS without
associated evidence of neurogenic changes on needle
EMG in the motor units recorded as fasciculations [10].
Such motor unit abnormalities were not seen. This
patient had findings that could be consistent with a
lower motor neuron variant of motor system disease,
but the sensory loss would argue for a polyneuropathy.
Sensory loss unless otherwise explained is considered
inconsistent with a diagnosis of ALS [3].
More striking were the atypical electrodiagnostic find-
ings for ALS. His electrodiagnostic studies contained all
of those features that have been reported as rare or not
present at all in ALS; namely, motor conduction veloci-
ties less than 70% of the lower limit of normal, distal
motor latencies greater than 125% of the upper limit of
normal, and F-wave latencies greater than 125% of the
upper limit of normal [11]. Although a large number of
criteria sets have been proposed for defining an acquired
demyelinating neuropathy electrodiagnostically, none
have really proven satisfactory [12]. Nevertheless, the
pattern of abnormalities in this patient would be compa-
tible with an acquired neuropathy with possible demyeli-
nating features. Most striking were the asymmetries
consistent with a multifocal process. Large differences in
motor conduction velocities between his legs were
observed on the initial electrodiagnostic examination,
even allowing for differences in evoked response ampli-
tudes. Also, in the repeat study, there were large differ-
ences between the median and ulnar nerves in the right
arm, even allowing for the prolonged median distal
motor latency [6]. Multifocal acquired demyelinating
sensory and motor neuropathy (MADSAM; Lewis-Sum-
ner syndrome) could be considered but characteristic
conduction block was not present. In addition, the rapid
progression with ultimate death in our patient would be
inconsistent with previous reports of the natural history
of MADSAM [13].
Three patients have recently been described who had
a polyneuropathy resembling CIDP but were thought to
have ALS [14]. Two patients had a family history of
ALS. There was no family history of ALS in our patient.
The only post mortem examination was performed on
one of the patients with famalial ALS. The mean disease
duration was 23 months with the shortest being 13 and
the longest 38, considerably longer than in our patient.
There have been two patients described in published
manuscripts with multifocal motor neuropathy (MMN)
and pathological changes of ALS [cited in reference
[14]]. There was no evidence for MMN in our patient
including absence of conduction block and GM1 antibo-
dies and rapid course. Our patient is therefore arguably
unique.
Electrodiagnostic studies in patients with possible ALS
are critical for not only aiding in the diagnosis but also
helping to provide information that could be consistent
with a different, potentially treatable, diagnosis. A main
consideration here would be a chronic acquired demyeli-
nating polyneuropathy [15]. Treatment of these neuropa-
thies can be costly and is not without risk. Studies such as
electrodiagnosis that can provide justification for such
treatments are therefore important. Our patient was treated
as if he may have had a chronic acquired demyelinating
neuropathy. Given the essentially invariably fatal outcome
of ALS, treatment for CIDP was probably justified.
Conclusions
This patient is a seemingly unique lesson on our limita-
tions in making the distinction between ALS and an
acquired, treatable neuropathy. Sensitivity to these issues
is important given the serious nature of ALS and the
resultant complexities in the management of such
patients.
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